HIV/AIDS Cohort Evaluation of a Single Center in the Context of "90-90-90" Targets
Özet
Objective: Human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) continues to be one of the most important health, social and safety issues faced by the global community. In 2014, the United Nations HIV/AIDS joint program (UNAIDS) proposed a new target for global anti-retroviral treatment (ART) program. This new target, known as "90-90-90", recommends that by 2020, 90% of all people living with HIV will be knowing their HIV serology, 90% of all people with diagnosed HIV infection will be receiving ART and 90% of all people on ART will achieve viral suppression. The aim of our study was to evaluate the HIV/AIDS cohort data of our clinic in the context of "90-90-90" targets. Methods: The medical records of HIV-infected patients followed in the Department of Infectious Diseases and Clinical Microbiology Ondokuz Mayis University Faculty of Medicine between 2005 and 2018 were reviewed retrospectively. Results: In our clinic, 336 HIV-infected patients were followed during the study period. Of these patients, 284 (84.5%) were male. Of the 317 surviving patients, 240 (75.7%) were examined at the outpatient clinic at least once within the last 6 months and 239 (75.3%) were on ART. According to the latest laboratory results of 239 patients on ART, virological suppression was achieved in 206 (86.1%) patients. In the analysis of 33 patients with a detectable viral load on ART, it was found that 11 patients were on ART for less than 6 months, 8 patients did not use their medication regularly, and one patient did not have a test result. Conclusions: Although it was determined that "90-90-90" targets are achievable within the scope of the patient group that we serve in our hospital, the compilation of nationwide data and screening programs to identify all HIV-infected patients in the community, will be guiding to achieve "90-90-90" targets.
